{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:33:45Z","timestamp":1793316825435,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.autrev.2023.103447","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T22:26:49Z","timestamp":1694644009000},"page":"103447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Risk of venous thromboembolism in autoimmune diseases: A comprehensive review"],"prefix":"10.1016","volume":"22","author":[{"given":"Danilo","family":"Menichelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito Maria","family":"Cormaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Marucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Franchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Sole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Capozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Fallarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103447_bb0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1358863X15573838","article-title":"Venous thromboembolism in systemic autoimmune diseases: a narrative review with emphasis on primary systemic vasculitides","volume":"20","author":"Tamaki","year":"2015","journal-title":"Vasc Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7015-9-1","article-title":"Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study","volume":"9","author":"Ramagopalan","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0015","first-page":"171","article-title":"Autoimmune diseases and venous thromboembolism: a review of the literature","volume":"2","author":"Zoller","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0020","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/bjh.17549","article-title":"I. Registro Informatizado de Enfermedad TromboEmbolica, Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbolica (RIETE) registry","volume":"194","author":"Borjas Howard","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2023.103447_bb0025","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and Management of the Antiphospholipid Syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0030","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2019.221945","article-title":"Seronegative antiphospholipid syndrome: refining the value of \"non-criteria\" antibodies for diagnosis and clinical management","volume":"105","author":"Pignatelli","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2023.103447_bb0035","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2023.103447_bb0040","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3233\/JAD-181294","article-title":"Relationship of antiphospholipid antibodies to risk of dementia: a systematic review","volume":"69","author":"Bucci","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-014-0485-9","article-title":"The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome","volume":"17","author":"Willis","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2023.103447_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12030891","article-title":"Advances in the pathophysiology of thrombosis in antiphospholipid syndrome: Molecular mechanisms and signaling through lipid rafts","volume":"12","author":"Capozzi","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0055","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/ATVBAHA.108.182204","article-title":"Venous thrombosis in the antiphospholipid syndrome","volume":"29","author":"Farmer-Boatwright","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2023.103447_bb0060","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/jth.14720","article-title":"Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism","volume":"18","author":"Miranda","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.autrev.2023.103447_bb0065","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The euro-phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103447_bb0070","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0075","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103447_bb0080","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1160\/TH04-12-0839","article-title":"Antibody profiles for the diagnosis of antiphospholipid syndrome","volume":"93","author":"Pengo","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2023.103447_bb0085","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103447_bb0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40744-022-00513-1","article-title":"Systematic literature review and Meta-analysis of venous thromboembolism events in systemic lupus erythematosus","volume":"10","author":"Bello","year":"2023","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2023.103447_bb0095","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103447_bb0100","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","article-title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","volume":"68","author":"Bernatsky","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0105","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/rheumatology\/keab851","article-title":"Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies","volume":"61","author":"Xiong","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2023.103447_bb0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TCRM.S157085","article-title":"Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis","volume":"14","author":"Li","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.autrev.2023.103447_bb0115","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acr.23560","article-title":"Venous thromboembolic events in idiopathic inflammatory myopathy: occurrence and relation to disease onset","volume":"70","author":"Antovic","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2023.103447_bb0120","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0125","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103447_bb0130","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel","year":"2008","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0135","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1186\/s13075-014-0435-y","article-title":"A meta-analysis of the risk of venous thromboembolism in inflammatory rheumatic diseases","volume":"16","author":"Lee","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103447_bb0140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1056\/NEJM199006073222302","article-title":"Activation of coagulation after administration of tumor necrosis factor to normal subjects","volume":"322","author":"van der Poll","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0145","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrrheum.2010.44","article-title":"The role of endothelial function and its assessment in rheumatoid arthritis","volume":"6","author":"Khan","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0150","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138161211795049813","article-title":"The role of coagulation in chronic inflammatory disorders: a jack of all trades","volume":"17","author":"Borensztajn","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.autrev.2023.103447_bb0155","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0160","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0165","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.chest.2016.09.009","article-title":"Association of sarcoidosis with increased risk of VTE: a population-based study, 1976 to 2013","volume":"151","author":"Ungprasert","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2023.103447_bb0170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1617146","article-title":"Inflammation, innate immunity and blood coagulation","volume":"30","author":"Xu","year":"2010","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.autrev.2023.103447_bb0175","first-page":"437","article-title":"Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease","volume":"133","author":"Chapman","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0180","first-page":"313","article-title":"Sjogren\u2019s syndrome","volume":"18","author":"Venables","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2796.1996.418817000.x","article-title":"A new model for classification of disease manifestations in primary Sjogren\u2019s syndrome: evaluation in a retrospective long-term study","volume":"239","author":"Asmussen","year":"1996","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0190","first-page":"746","article-title":"Risk of venous thromboembolism in patients with Sjogren\u2019s syndrome: a systematic review and meta-analysis","volume":"33","author":"Ungprasert","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0195","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3899\/jrheum.131345","article-title":"Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study","volume":"41","author":"Chung","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0200","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3899\/jrheum.160185","article-title":"The risk of deep venous thrombosis and pulmonary embolism in primary Sjogren syndrome: a general population-based study","volume":"44","author":"Avina-Zubieta","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.autrev.2012.05.002","article-title":"Venous thromboembolic disease in systemic autoimmune diseases: an association to keep in mind","volume":"12","author":"Silvarino","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103447_bb0210","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/acr.20322","article-title":"Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin","volume":"63","author":"Bartoloni","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2023.103447_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/0961203304lu1006oa","article-title":"Antiphospholipid antibodies in primary Sjogren\u2019s syndrome: prevalence and clinical significance in a series of 74 patients","volume":"13","author":"Fauchais","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2023.103447_bb0220","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/joim.12941","article-title":"Concomitant Ro\/SSA and La\/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjogren's syndrome","volume":"286","author":"Mofors","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.autrev.2013.11.010","article-title":"Diagnosis and classification of autoimmune hemolytic anemia","volume":"13","author":"Bass","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103447_bb0230","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(67)90168-4","article-title":"Idiopathic acquired autoimmune hemolytic anemia. A review of forty-seven cases treated from 1955 through 1965","volume":"43","author":"Allgood","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0235","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.autrev.2015.07.001","article-title":"Venous thromboembolism related to warm autoimmune hemolytic anemia: a case-control study","volume":"14","author":"Lecouffe-Desprets","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103447_bb0240","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/1024533021000059474","article-title":"Auto-immune haemolytic anaemia--a high-risk disorder for thromboembolism?","volume":"8","author":"Hendrick","year":"2003","journal-title":"Hematology"},{"key":"10.1016\/j.autrev.2023.103447_bb0245","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.thromres.2015.09.004","article-title":"Autoimmune hemolytic anemia and venous thromboembolism: a systematic review and meta-analysis","volume":"136","author":"Ungprasert","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2023.103447_bb0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207218","article-title":"Venous thromboembolic events during warm autoimmune hemolytic anemia","volume":"13","author":"Audia","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103447_bb0255","doi-asserted-by":"crossref","first-page":"16256","DOI":"10.1016\/S0021-9258(18)98544-3","article-title":"Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function","volume":"266","author":"Ruf","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2023.103447_bb0260","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1182\/blood-2014-07-589283","article-title":"Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease","volume":"125","author":"Camus","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103447_bb0265","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1021\/bi00362a005","article-title":"Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine","volume":"25","author":"Bach","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.autrev.2023.103447_bb0270","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","article-title":"Novel paradigms in systemic lupus erythematosus","volume":"393","author":"Dorner","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103447_bb0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12959-015-0043-3","article-title":"Systemic lupus erythematosus and thrombosis","volume":"13","author":"Bazzan","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.autrev.2023.103447_bb0280","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103447_bb0285","doi-asserted-by":"crossref","first-page":"4","DOI":"10.55563\/clinexprheumatol\/nolysy","article-title":"One year in review 2022: systemic lupus erythematosus","volume":"40","author":"Zucchi","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2014.10.012","article-title":"Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees","volume":"135","author":"Yusuf","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2023.103447_bb0295","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/ard.2008.093013","article-title":"Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort","volume":"68","author":"Kaiser","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2023.103447_bb0305","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/CLEP.S191418","article-title":"Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease","volume":"11","author":"Bergamasco","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.autrev.2023.103447_bb0310","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2004.09.001","article-title":"Epidemiology of systemic sclerosis in Northwest Greece 1981 to 2002","volume":"34","author":"Alamanos","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103447_bb0315","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MD.0b013e318189372f","article-title":"Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study","volume":"87","author":"Arias-Nunez","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2023.103447_bb0320","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0325","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.revmed.2007.07.010","article-title":"Systemic sclerosis in men","volume":"29","author":"Gaultier","year":"2008","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2023.103447_bb0330","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103447_bb0335","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/08916939908994064","article-title":"Autoimmunity and vascular involvement in systemic sclerosis (SSc)","volume":"31","author":"Kahaleh","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2023.103447_bb0340","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.semarthrit.2010.10.002","article-title":"Coagulation and autoimmunity in scleroderma interstitial lung disease","volume":"41","author":"Ludwicka-Bradley","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103447_bb0345","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11926-009-0015-3","article-title":"Is scleroderma a vasculopathy?","volume":"11","author":"Fleming","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2023.103447_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/BOR.0000000000000134","article-title":"Classification and classification criteria for vasculitis: achievements, limitations and prospects","volume":"27","author":"Mahr","year":"2015","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0355","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s10067-016-3394-7","article-title":"Risk of venous thromboembolism among patients with vasculitis: a systematic review and meta-analysis","volume":"35","author":"Ungprasert","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0360","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s10067-021-05589-8","article-title":"Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression","volume":"40","author":"Hansrivijit","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270142","article-title":"Increased risk of venous thromboembolism in patients with granulomatosis with polyangiitis: a population-based study","volume":"17","author":"Marozoff","year":"2022","journal-title":"PloS One"},{"key":"10.1016\/j.autrev.2023.103447_bb0370","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1093\/rheumatology\/keab071","article-title":"Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study","volume":"60","author":"Moiseev","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103447_bb0375","doi-asserted-by":"crossref","first-page":"105498","DOI":"10.1016\/j.jbspin.2022.105498","article-title":"Risk of acute myocardial infarction, stroke, and venous thromboembolism among patients with anti-neutrophil cytoplasmic antibody-associated vasculitis in South Korea: a nationwide population-based study","volume":"90","author":"Ahn","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2023.103447_bb0380","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11239-022-02637-1","article-title":"Arterial and venous involvement in Behcet\u2019s syndrome: a narrative review","volume":"54","author":"Toledo-Samaniego","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.autrev.2023.103447_bb0385","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s11739-018-1991-y","article-title":"Vascular Behcet's syndrome: an update","volume":"14","author":"Emmi","year":"2019","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0390","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10067-007-0685-z","article-title":"Treatment of venous thrombosis associated with Behcet\u2019s disease: immunosuppressive therapy alone versus immunosuppressive therapy plus anticoagulation","volume":"27","author":"Ahn","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0395","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Behcet's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0400","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.crohns.2013.09.021","article-title":"Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-analysis of observational studies","volume":"8","author":"Fumery","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103447_bb0405","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/apt.12294","article-title":"Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease","volume":"37","author":"Yuhara","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.autrev.2023.103447_bb0410","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1055\/s-0037-1615600","article-title":"The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study","volume":"85","author":"Bernstein","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2023.103447_bb0415","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(09)61963-2","article-title":"Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study","volume":"375","author":"Grainge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103447_bb0420","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/gut.2010.228585","article-title":"Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study","volume":"60","author":"Kappelman","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.autrev.2023.103447_bb0425","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/ibd\/izy058","article-title":"Incidence and risk factor analysis of thromboembolic events in east Asian patients with inflammatory bowel disease, a multinational collaborative study","volume":"24","author":"Weng","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0430","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41598-021-81657-y","article-title":"Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study","volume":"11","author":"Heo","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2023.103447_bb0435","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.crohns.2012.10.008","article-title":"Clinical presentation of venous thromboembolism in inflammatory bowel disease","volume":"7","author":"Papay","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.autrev.2023.103447_bb0440","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.3748\/wjg.v27.i40.6757","article-title":"Venous and arterial thromboembolism in patients with inflammatory bowel diseases","volume":"27","author":"Stadnicki","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103447_bb0445","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2010.05.026","article-title":"Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism","volume":"139","author":"Novacek","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103447_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MEG.0000000000000495","article-title":"Thromboembolism as an important complication of inflammatory bowel disease","volume":"28","author":"Bollen","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0455","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12959-015-0044-2","article-title":"Thrombosis in inflammatory bowel diseases: what's the link?","volume":"13","author":"Giannotta","year":"2015","journal-title":"Thromb J"},{"key":"10.1016\/j.autrev.2023.103447_bb0460","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","article-title":"Venous thromboembolism in inflammatory bowel disease","volume":"26","author":"Cheng","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103447_bb0465","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.3748\/wjg.v20.i12.3173","article-title":"Venous thromboembolism in patients with inflammatory bowel disease: focus on prevention and treatment","volume":"20","author":"Papa","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103447_bb0470","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.autrev.2004.03.002","article-title":"Inflammatory bowel disease: the role of environmental factors","volume":"3","author":"Danese","year":"2004","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2023.103447_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1572-0241.2006.00943.x","article-title":"Inflammation and coagulation in inflammatory bowel disease: the clot thickens","volume":"102","author":"Danese","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103447_bb0480","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1089\/ars.2016.6839","article-title":"Is there an interplay between adherence to Mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients?","volume":"25","author":"Pastori","year":"2016","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.autrev.2023.103447_bb0485","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.numecd.2017.06.007","article-title":"Low-grade endotoxemia, gut permeability and platelet activation in patients with impaired fasting glucose","volume":"27","author":"Carnevale","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0490","first-page":"205","article-title":"Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance","volume":"6","author":"Caradonna","year":"2000","journal-title":"J Endotoxin Res"},{"key":"10.1016\/j.autrev.2023.103447_bb0495","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","article-title":"Venous thrombosis and prothrombotic factors in inflammatory bowel disease","volume":"20","author":"Magro","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.autrev.2023.103447_bb0500","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1023\/A:1026602803622","article-title":"Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease","volume":"43","author":"Koutroubakis","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2023.103447_bb0505","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1005675921664","article-title":"Reduced free protein S levels in patients with inflammatory bowel disease: prevalence, clinical relevance, and role of anti-protein S antibodies","volume":"46","author":"Saibeni","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.autrev.2023.103447_bb0510","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.autrev.2023.103447_bb0515","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejim.2021.11.001","article-title":"Optimal duration of anticoagulation therapy for venous thromboembolism in autoimmune diseases","volume":"95","author":"Yamashita","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0520","doi-asserted-by":"crossref","first-page":"715878","DOI":"10.3389\/fcvm.2021.715878","article-title":"Use of direct Oral anticoagulants in patients with antiphospholipid syndrome: a systematic review and comparison of the international guidelines","volume":"8","author":"Pastori","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.autrev.2023.103447_bb0525","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0530","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0535","article-title":"Thrombosis and anticoagulation therapy in systemic lupus erythematosus","volume":"2022","author":"Yuan","year":"2022","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.autrev.2023.103447_bb0540","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.thromres.2020.06.005","article-title":"Venous thromboembolic events in inflammatory bowel diseases: a review of current evidence and guidance on risk in the post-hospitalization setting","volume":"194","author":"Murthy","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2023.103447_bb0545","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2014.01.042","article-title":"Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology","volume":"146","author":"Nguyen","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.autrev.2023.103447_bb0550","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2023.103447_bb0555","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1055\/s-0040-1721733","article-title":"Autoimmune hemolytic anemia and pulmonary embolism: an association to consider","volume":"5","author":"Solari","year":"2021","journal-title":"TH Open"},{"key":"10.1016\/j.autrev.2023.103447_bb0560","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0565","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3899\/jrheum.110765","article-title":"Warfarin in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension. A Bayesian approach to evaluating treatment for uncommon disease","volume":"39","author":"Johnson","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0570","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/OARRR.S284757","article-title":"Venous thromboembolism in rheumatoid arthritis: the added effect of disease activity to traditional risk factors","volume":"14","author":"Omair","year":"2022","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.autrev.2023.103447_bb0575","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1055\/s-0040-1721735","article-title":"Anticoagulation for patients with venous thromboembolism: when is extended treatment required?","volume":"4","author":"Weitz","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.autrev.2023.103447_bb0580","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011028","article-title":"Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocol","volume":"6","author":"Calderone","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.autrev.2023.103447_bb0585","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/asheducation-2016.1.707","article-title":"Prevention of thrombosis in antiphospholipid syndrome","volume":"2016","author":"Lim","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.autrev.2023.103447_bb0590","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1182\/blood-2013-04-496257","article-title":"Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review","volume":"122","author":"Garcia","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2023.103447_bb0595","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Zoller","year":"2012","journal-title":"Lancet"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:28:34Z","timestamp":1761600514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":119,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1568997223001817"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103447","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of venous thromboembolism in autoimmune diseases: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103447"}}